CRCA vs. KORU
CRCA (ProShares Ultra CRCL) and KORU (Direxion Daily MSCI South Korea Bull 3X Shares) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while KORU is a South Korea Equities fund tracking the MSCI Korea 25/50 Index. CRCA is actively managed, while KORU is passively managed. At a 0.31 correlation, their price movements are largely independent. CRCA charges 0.95%/yr vs 1.32%/yr for KORU.
Performance
CRCA vs. KORU - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -68.22% return, which is significantly lower than KORU's 130.89% return.
CRCA
- 1D
- -9.58%
- 1M
- -40.68%
- 6M
- -70.42%
- YTD
- -68.22%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
KORU
- 1D
- -24.74%
- 1M
- -49.18%
- 6M
- 66.57%
- YTD
- 130.89%
- 1Y
- 413.07%
- 3Y*
- 60.31%
- 5Y*
- 1.85%
- 10Y*
- 6.31%
CRCA vs. KORU - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -68.22% | -84.67% |
KORU Direxion Daily MSCI South Korea Bull 3X Shares | 130.89% | 120.30% |
Correlation
The correlation between CRCA and KORU is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. KORU — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
KORU
CRCA vs. KORU - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Direxion Daily MSCI South Korea Bull 3X Shares (KORU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | KORU | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.40 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 6.23 | — |
| Martin ratioReturn relative to average drawdown | — | 17.42 | — |
Loading charts...
Drawdowns
CRCA vs. KORU - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.18%, roughly equal to the maximum KORU drawdown of -95.79%. Use the drawdown chart below to compare losses from any high point for CRCA and KORU.
Loading charts...
Drawdown Indicators
| CRCA | KORU | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.18% | -95.79% | +0.61% |
Max Drawdown (1Y)Largest decline over 1 year | — | -66.86% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -73.34% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -92.82% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -95.79% | — |
Current DrawdownCurrent decline from peak | -95.13% | -66.86% | -28.27% |
Average DrawdownAverage peak-to-trough decline | -72.99% | -57.39% | -15.60% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 23.85% | — |
Volatility
CRCA vs. KORU - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | KORU | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 78.13% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 145.83% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 195.27% | 150.12% | +45.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 195.27% | 93.49% | +101.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 195.27% | 84.08% | +111.19% |
CRCA vs. KORU - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is lower than KORU's 1.32% expense ratio.
Dividends
CRCA vs. KORU - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 6.93%, more than KORU's 0.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 6.93% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KORU Direxion Daily MSCI South Korea Bull 3X Shares | 0.38% | 0.89% | 4.10% | 2.55% | 0.48% | 0.76% | 0.01% | 0.93% | 1.40% | 3.59% |
Frequently Asked Questions
CRCA and KORU have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CRCA is cheaper at 0.95% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CRCA is cheaper with a 0.95% expense ratio, compared with 1.32% for KORU.
CRCA has the higher dividend yield at 6.93%, compared with 0.38% for KORU.
CRCA is categorized as Leveraged Equities, while KORU is South Korea Equities. They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for CRCA and 1.32% for KORU.
Find the right allocation for CRCA and KORU
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer